Understanding Maternal Serum AFP Levels

Maternal serum $\alpha$-fetoprotein (AFP) is a protein produced by the baby (fetus) and the yolk sac during pregnancy. Measuring its level in the mother's blood is part of prenatal screening.

Conditions Associated with Elevated AFP

Elevated maternal serum AFP levels typically indicate a potential problem with the baby's development. Key conditions where AFP is usually higher than normal include:

• Neural tube defects: Such as anencephaly and spina bifida, where the baby's brain or spinal cord doesn't close properly, allowing AFP to leak into the amniotic fluid and then into the mother's blood.
• Ventral wall defects: Conditions like omphalocele (where organs are outside the body) and gastroschisis (a hole in the abdominal wall) allow fetal proteins to enter the maternal circulation.
• Intrauterine fetal death: When a fetus has died, its tissues break down, releasing AFP into the maternal bloodstream.
• Multiple gestation: Having twins or more babies generally leads to higher AFP levels.
• Other issues like certain kidney conditions or inaccurate dating of the pregnancy can also cause elevated levels.

Identifying the Exception: Down Syndrome

Down syndrome (Trisomy 21) is a genetic condition. Unlike the conditions listed above, maternal serum AFP levels are typically lower than normal in pregnancies affected by Down syndrome. Screening protocols for Down syndrome often look for decreased AFP, along with decreased estriol and increased human chorionic gonadotropin (hCG).

Therefore, Down syndrome is the condition among the options where maternal serum AFP levels are NOT elevated.